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Summary. Inflammation is characterized by the 
recruitment of leukocytes from the vasculature. Recent 
studies have implicated chemokines as an important 
class of mediators that function principally to stimulate 
leukocyte recruitment, and in some cases, leukocyte 
activity. There are four defined chemokine subfamilies 
based on their primary structure, CXC, CC, C and 
CX3C. Members of the CC chemokine subfamily, such 
as monocyte chemoattractant protein 1 (MCP-l), are 
chemotactic for monocytes and other leukocyte subsets. 
The studies described below focus on the expression of 
MCP-1 in vitro and in vivo in an osseous environment. 
These studies indicate that MCP-1 is typically not 
expressed in  normal bone or by normal osteoblasts in 
vitro. Upon stimulation by inflammatory mediators, 
MCP-1 is up-regulated. This expression is temporally 
and spatially associated with the recruitment of 
monocytes in both osseous inflammation and during 
developmentally regulated bone remodelling. Further- 
more, exogenous MCP-1 applied to inflamed bone 
enhances the recruitment of monocytes. Because 
monocytes produce factors that influence osseous 
metabolism, including but not limited to prostglandins, 
platelet-derived growth factor, interleukin-l or tumor 
necrosis factor, chemokines that initiate their recruitment 
are likely to be highly important. 
Key words: Bone, Chemokine, Cytokine, Osteoblast, 
Osteoclast, Review 
Introduction 
Chemokines are low molecular weight secretory 
proteins that function principally as stirnulators of 
leukocyte recruitment.  These secondary pro- 
inflammatory mediators are  induced by primary 
proinflammatory mediators (e.g., IL-l and TNF). There 
are four defined chemokine subfamilies based on their 
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primary structure, CXC, CC, C and CX3C. The best 
characterized chemokines are CXC and CC families. 
Members of the CC chemokine subfamily, such as 
monocyte chemoattractant protein 1 (MCP-l ) ,  
RANTES, MIP-1-y and MIP-la ,  are chemotactic for 
monocytes, subsets of lymphocytes and natural killer 
cells, (Graves and Jiang, 1995), whereas CXC chemo- 
kines generally, but not exclusively, induce neutrophil 
chemotaxis and recruitment to tissue. 
MCP-l ,  a monomeric polypeptide, is typically 
secreted in two predominant forms with molecular 
weights of 9 and 13 kD. Lectin blots indicate that the 
disaccharide, galactose-B-3D-N-acetyl galactosamine is 
present on the 13 kD MCP-1 isoform but not the 9 kD 
isoform (Fig. 1). MCP-1 induces recruitment of 
monocytes, a subset of T lymphocytes, eosinophils, and 
basophils  (Graves and Jiang, 1995). Significant 
expression of MCP-1 in normal cells usually requires 
stimulation with pro-inflammatory agents (Williams et 
al., 1992).  In contrast,  MCP- l  appears  to  be 
constitutively produced by different human tumors and 
may account for much of the monocyte chemotactic 
activity produced by tumor cells (Bottazzi et al., 1983; 
Graves et al., 1989; Van Damme et al., 1992; Zhang et 
al., 1997). MCP-1 was first isolated by Valente and co- 
workers  (Valente et al., 1988)  and sequenced by 
Yoshimura and colleagues and Furutani and co-workers 
(Yoshimura e t  al., 1989;  Furutani e t  al., 1989).  
Functional assays demonstrated the similarity between 
the chemotactic factors produced by human bone tumors 
(MG-63) and primate smooth muscle cells (Graves et al., 
1989). The murine form of MCP-l,  JE, was initially 
identified as an immediate early gene induced in 
response to platelet-derived growth factor (Cochran et 
al., 1983) and its properties have been described in a 
series of articles by Rollins and co-workers (reviewed in 
Rollins, 1997). 
It is striking that MCP-1 is expressed in a number of 
inflammatory conditions associated with monocyte 
recruitment,  including delayed hypersensitivity 
reactions, atherosclerosis pulmonary fibrosis, bacterial 
infection, arthritis, and renal disease (Graves and Jiang, 
1995). MCP-1 stimulates monocyte chemotaxis, as well 







